Exposure-response analysis of oral and intravenous imatinib in critically ill patients with COVID-19 acute respiratory distress syndrome

Authors

Institutions

Publication Details

Journal
European Journal of Pharmaceutical Sciences
Published
2025-10-17
DOI
https://doi.org/10.1016/j.ejps.2025.107332
Primary Topic
Neuroendocrine Tumor Research Advances
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exposure-response analysis of oral and intravenous imatinib in critically ill patients with COVID-19 acute respiratory distress syndrome

Medhat M. Said, Å. Braam, Jurjan Aman, Jos W. R. Twisk et al.
European Journal of Pharmaceutical Sciences
Neuroendocrine Tumor Research Advances
article

Exposure-response analysis of oral and intravenous imatinib in critically ill patients with COVID-19 acute respiratory distress syndrome

Medhat M. Said, Å. Braam, Jurjan Aman, Jos W. R. Twisk, Harm Jan Bogaard, Leila N. Atmowihardjo, Eleonora L. Swart, Job R. Schippers, Erik Duijvelaar, Imke H. Bartelink
article en

Abstract

No abstract available for this paper.
European Journal of Pharmaceutical SciencesVol. 215
Amsterdam Neuroscience (NL), Amsterdam University Medical Centers (NL), Institute of Infection and Immunity (CA)
European Commission, ZonMw, Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Openalex Percentile: Top 60%
Neuroendocrine Tumor Research Advances
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.